Literature DB >> 15184102

Linkage studies of schizophrenia.

Brien Riley1.   

Abstract

The study of schizophrenia genetics has revealed much about the disease but none of the essential secrets of its etiology, so far, for numerous reasons. First, schizophrenia is a complex trait, influenced by both genes and environment. Second, it appears to be a highly heterogeneous disease, with locus and allelic heterogeneity both between and within families likely. Third, since it is common, it is likely that the genetic liability variants are common, and so are found with relatively high frequency in the general population. Fourth, linkage methods, which deliver rapid coverage of the genome, have great power to identify single genes causing Mendelian disorders but are poorly suited to the genetic architecture of complex traits. Although association methods are undeniably more powerful in such situations, affordable technologies to deliver the much higher density whole genome coverage required are not yet available and candidate gene studies of schizophrenia have not produced robust and replicable results. In spite of these limitations, there are now sufficient data to support several conclusions. Numerous regions of the human genome give consistent, though by no means unanimous, support for linkage. The precise nature of these signals is not yet understood, and power to position the effects is poor, but metanalyses show the co-occurrence is unlikely to be due to chance. Combined approaches utilizing linkage for rapid genome coverage and association for fine-scale follow-up have identified several promising candidate genes. Although the definition of replication in a complex trait is itself complex, a number of these candidates have been supported by numerous studies. These converging lines of evidence suggest that the genetics of schizophrenia, long considered a most intractable problem, are at last beginning to be unraveled. Copyright 2004 FP Graham Publishing Co.

Entities:  

Mesh:

Year:  2004        PMID: 15184102     DOI: 10.1007/bf03033293

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  81 in total

1.  A schizophrenia locus may be located in region 10p15-p11.

Authors:  R E Straub; C J MacLean; R B Martin; Y Ma; M V Myakishev; C Harris-Kerr; B T Webb; F A O'Neill; D Walsh; K S Kendler
Journal:  Am J Med Genet       Date:  1998-07-10

2.  Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium.

Authors:  S V Faraone; T Matise; D Svrakic; J Pepple; D Malaspina; B Suarez; C Hampe; C T Zambuto; K Schmitt; J Meyer; P Markel; H Lee; J Harkavy Friedman; C Kaufmann; C R Cloninger; M T Tsuang
Journal:  Am J Med Genet       Date:  1998-07-10

3.  Localization of a susceptibility locus for schizophrenia on chromosome 5.

Authors:  R Sherrington; J Brynjolfsson; H Petursson; M Potter; K Dudleston; B Barraclough; J Wasmuth; M Dobbs; H Gurling
Journal:  Nature       Date:  1988-11-10       Impact factor: 49.962

Review 4.  Linkage results in schizophrenia.

Authors:  M Baron
Journal:  Am J Med Genet       Date:  1996-04-09

Review 5.  The TDT and other family-based tests for linkage disequilibrium and association.

Authors:  R S Spielman; W J Ewens
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

6.  A highly significant association between a COMT haplotype and schizophrenia.

Authors:  Sagiv Shifman; Michal Bronstein; Meira Sternfeld; Anne Pisanté-Shalom; Efrat Lev-Lehman; Avraham Weizman; Ilya Reznik; Baruch Spivak; Nimrod Grisaru; Leon Karp; Richard Schiffer; Moshe Kotler; Rael D Strous; Marnina Swartz-Vanetik; Haim Y Knobler; Eilat Shinar; Jacques S Beckmann; Benjamin Yakir; Neil Risch; Naomi B Zak; Ariel Darvasi
Journal:  Am J Hum Genet       Date:  2002-10-25       Impact factor: 11.025

7.  Analysis of chromosome 22 markers in nine schizophrenia pedigrees.

Authors:  H Coon; J Holik; M Hoff; F Reimherr; P Wender; M Myles-Worsley; M Waldo; R Freedman; W Byerley
Journal:  Am J Med Genet       Date:  1994-03-15

8.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives.

Authors:  A E Pulver; G Nestadt; R Goldberg; R J Shprintzen; M Lamacz; P S Wolyniec; B Morrow; M Karayiorgou; S E Antonarakis; D Housman
Journal:  J Nerv Ment Dis       Date:  1994-08       Impact factor: 2.254

9.  Mental illness in the biological and adoptive relatives of schizophrenic adoptees. Replication of the Copenhagen Study in the rest of Denmark.

Authors:  S S Kety; P H Wender; B Jacobsen; L J Ingraham; L Jansson; B Faber; D K Kinney
Journal:  Arch Gen Psychiatry       Date:  1994-06

10.  Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition.

Authors:  A E Farmer; P McGuffin; I I Gottesman
Journal:  Arch Gen Psychiatry       Date:  1987-07
View more
  12 in total

Review 1.  Gene-environment interplay in schizopsychotic disorders.

Authors:  Tomas Palomo; Trevor Archer; Richard M Kostrzewa; Rrichard J Beninger
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 2.  A generic research paradigm for identification and validation of early molecular diagnostics and new therapeutics in common disorders.

Authors:  Keith D Coon; Travis L Dunckley; Dietrich A Stephan
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

3.  The DLX1and DLX2 genes and susceptibility to autism spectrum disorders.

Authors:  Xudong Liu; Natalia Novosedlik; Ami Wang; Melissa L Hudson; Ira L Cohen; Albert E Chudley; Cynthia J Forster-Gibson; Suzanne M E Lewis; Jeanette J A Holden
Journal:  Eur J Hum Genet       Date:  2008-08-27       Impact factor: 4.246

4.  Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Rajendra D Badgaiyan; Tomas Palomo; Mark S Gold
Journal:  Med Hypotheses       Date:  2014-02-26       Impact factor: 1.538

5.  Support for the homeobox transcription factor gene ENGRAILED 2 as an autism spectrum disorder susceptibility locus.

Authors:  Rym Benayed; Neda Gharani; Ian Rossman; Vincent Mancuso; Gloria Lazar; Silky Kamdar; Shannon E Bruse; Samuel Tischfield; Brett J Smith; Raymond A Zimmerman; Emanuel Dicicco-Bloom; Linda M Brzustowicz; James H Millonig
Journal:  Am J Hum Genet       Date:  2005-10-05       Impact factor: 11.025

Review 6.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 7.  Statistical genetics concepts and approaches in schizophrenia and related neuropsychiatric research.

Authors:  Nicholas J Schork; Tiffany A Greenwood; David L Braff
Journal:  Schizophr Bull       Date:  2006-10-11       Impact factor: 9.306

Review 8.  Schizophrenia genetics: putting all the pieces together.

Authors:  Simon L Girard; Patrick A Dion; Guy A Rouleau
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

9.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

Review 10.  Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?

Authors:  S Bender; M Weisbrod; F Resch
Journal:  J Neural Transm (Vienna)       Date:  2007-05-21       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.